Your browser doesn't support javascript.
loading
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.
Pisapia, Pasquale; Malapelle, Umberto; Roma, Gianluca; Saddar, Sonika; Zheng, Qi; Pepe, Francesco; Bruzzese, Dario; Vigliar, Elena; Bellevicine, Claudio; Luthra, Rajyalakshmi; Nikiforov, Yuri E; Mayo-de-Las-Casas, Clara; Molina-Vila, Miguel Angel; Rosell, Rafael; Bihl, Michel; Savic, Spasenija; Bubendorf, Lukas; de Biase, Dario; Tallini, Giovanni; Hwang, David H; Sholl, Lynette M; Vander Borght, Sara; Weynand, Birgit; Stieber, Daniel; Vielh, Philippe; Rappa, Alessandra; Barberis, Massimo; Fassan, Matteo; Rugge, Massimo; De Andrea, Carlos E; Lozano, Maria D; Lupi, Cristiana; Fontanini, Gabriella; Schmitt, Fernando; Dumur, Catherine I; Bisig, Bettina; Bongiovanni, Massimo; Merkelbach-Bruse, Sabine; Büttner, Reinhard; Nikiforova, Marina N; Roy-Chowdhuri, Sinchita; Troncone, Giancarlo.
Afiliación
  • Pisapia P; Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Roma G; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
  • Saddar S; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
  • Zheng Q; AccuRef Diagnostics, Applied Stem Cell, Inc, Milpitas, California.
  • Pepe F; Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Bruzzese D; Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Vigliar E; Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Bellevicine C; Department of Public Health, University of Naples Federico II, Naples, Italy.
  • Luthra R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nikiforov YE; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Mayo-de-Las-Casas C; Laboratory of Oncology, Pangaea Oncology, Barcelona, Spain.
  • Molina-Vila MA; Laboratory of Oncology, Pangaea Oncology, Barcelona, Spain.
  • Rosell R; Catalan Institute of Oncology, Badalona, Spain.
  • Bihl M; Rosell Cancer Institute, Quiròn-Dexeus University Institute, Barcelona, Spain.
  • Savic S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Bubendorf L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • de Biase D; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Tallini G; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Hwang DH; Anatomic Pathology, University of Bologna Medical Center, Bologna, Italy.
  • Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Vander Borght S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Weynand B; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Stieber D; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
  • Vielh P; National Health Laboratory, Dudelange, Luxembourg.
  • Rappa A; National Health Laboratory, Dudelange, Luxembourg.
  • Barberis M; Division of Pathology, European Institute of Oncology, Milan, Italy.
  • Fassan M; Division of Pathology, European Institute of Oncology, Milan, Italy.
  • Rugge M; Surgical Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • De Andrea CE; Surgical Pathology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Lozano MD; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
  • Lupi C; Department of Pathology, University Clinic of Navarra, Pamplona, Spain.
  • Fontanini G; Department of Surgical, Medical, and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Schmitt F; Department of Surgical, Medical, and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Dumur CI; Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.
  • Bisig B; Department of Pathology, Medical Faculty, Porto University, Porto, Portugal.
  • Bongiovanni M; Department of Pathology, Virginia Commonwealth University, Richmond, Virginia.
  • Merkelbach-Bruse S; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
  • Büttner R; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
  • Nikiforova MN; Institute of Pathology and Center for Molecular Medicine, University of Cologne, Cologne, Germany.
  • Roy-Chowdhuri S; Institute of Pathology and Center for Molecular Medicine, University of Cologne, Cologne, Germany.
  • Troncone G; Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Cancer Cytopathol ; 127(5): 285-296, 2019 05.
Article en En | MEDLINE | ID: mdl-31021538
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Análisis Mutacional de ADN / Biomarcadores de Tumor / Citodiagnóstico / Secuenciación de Nucleótidos de Alto Rendimiento / Mutación / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cancer Cytopathol Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Análisis Mutacional de ADN / Biomarcadores de Tumor / Citodiagnóstico / Secuenciación de Nucleótidos de Alto Rendimiento / Mutación / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Cancer Cytopathol Año: 2019 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos